INDV vs. SOPH, ITH, HCM, GRI, SLS, ERGO, BMY, SLN, AMYT, and OGN
Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.
Indivior vs.
Indivior (LON:INDV) and Sophos Group plc (SOPH.L) (LON:SOPH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.
Indivior presently has a consensus price target of GBX 1,650, suggesting a potential upside of 139.65%. Given Indivior's stronger consensus rating and higher probable upside, analysts clearly believe Indivior is more favorable than Sophos Group plc (SOPH.L).
Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 2.2%. Sophos Group plc (SOPH.L) pays an annual dividend of GBX 0.04 per share. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Sophos Group plc (SOPH.L) pays out 2.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Indivior is clearly the better dividend stock, given its higher yield and lower payout ratio.
Sophos Group plc (SOPH.L) has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks.
Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to Indivior's net margin of -0.17%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat Indivior's return on equity.
Indivior received 142 more outperform votes than Sophos Group plc (SOPH.L) when rated by MarketBeat users. Likewise, 80.43% of users gave Indivior an outperform vote while only 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote.
In the previous week, Indivior had 20 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 20 mentions for Indivior and 0 mentions for Sophos Group plc (SOPH.L). Indivior's average media sentiment score of 0.35 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that Indivior is being referred to more favorably in the media.
86.0% of Indivior shares are owned by institutional investors. 3.4% of Indivior shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Indivior beats Sophos Group plc (SOPH.L) on 13 of the 17 factors compared between the two stocks.
Get Indivior News Delivered to You Automatically
Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Indivior Competitors List
Related Companies and Tools
This page (LON:INDV) was last updated on 2/21/2025 by MarketBeat.com Staff
